Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Thomas Jefferson University
OHSU Knight Cancer Institute
AIDS Malignancy Consortium
City of Hope Medical Center
University of California, San Francisco
National Cancer Institute (NCI)